Kazia Therapeutics Ltd.

KZIA·NASDAQ·$12.51Share Price as of 11/2·$20MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)11/07/25 20-FAnnual report (foreign)11/15/24 20-FAnnual report (foreign)10/26/23 20-FAnnual report (foreign)10/17/22 20-FAnnual report (foreign)10/07/21

Disclosures

6-KForeign issuer report09/22/26 6-KForeign issuer report09/18/26 6-KForeign issuer report09/01/26 6-KForeign issuer report08/31/26 6-KForeign issuer report08/31/26

Prospectuses and Registrations

424B3Prospectus09/22/26 424B3Prospectus09/22/26 424B3Prospectus09/22/26 424B3Prospectus09/22/26 424B3Prospectus09/18/26

Proxies

No matching filings.

Ownership

SC 13G/ABeneficial ownership (amended)10/02/26 SC 13G/ABeneficial ownership (amended)08/19/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/08/26

Other

EFFECTRequest for effectiveness03/27/26 CORRESPCorrespondence with the SEC03/26/26 UPLOADLetter from the SEC03/25/26 EFFECTRequest for effectiveness12/23/25 EFFECTRequest for effectiveness12/23/25